CNS Stock Analysis: Buy, Sell, or Hold?
CNS - Cohen & Steers Inc.
$72.62
1.17 (1.64%)
▲
5d:
+0.65%
30d:
+8.92%
90d:
+9.76%
HOLD
MODERATE Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: Jul 16, 2026
Get Alerted When CNS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CNS is fairly valued with market pricing in 1.7% annual growth. Fine to hold or accumulate slowly on dips.
📊 HOLD: CNS is fairly valued with market pricing in 1.7% annual growth. Fine to hold or accumulate slowly on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$96.34
Based on 7.3% avg growth
INTRINSIC VALUE TODAY
$59.82
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 18.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CNS is currently trading at $72.62, which is considered extended relative to its 30-day fair value range of $66.02 to $71.56. The stock's valuation (Forward PE: 19.1) is in line with its historical norms (18.1). At these levels, the market is pricing in 1.7% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CNS is in a uptrend. The price is approaching resistance at $74.01. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CNS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CNS is in a uptrend. The price is approaching resistance at $74.01. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CNS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$66.02 -
$71.56
Company Quality Score
64/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
55.7%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Trading above Wall St target ($66.00)
- NEUTRAL: Market pricing in 1.7% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$66.02 -
$71.56
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$68.33
Resistance Level
$74.01
Current Trend
Uptrend
Technical data as of
May 18, 2026
Fundamental Context
Forward P/E (Next Year Est.)
19.07
Wall Street Target
$66.00
(-7.6%)
Revenue Growth (YoY)
8.3%
Earnings Growth (YoY)
6.5%
Profit Margin
27.5%
Valuation Premium vs History
+1.7% premium
PE vs Historical
19.1 vs 18.1
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+1.7%
(market-implied from PE analysis)
1-Year Target
$72.66
(+2%)
2-Year Target
$73.90
(+3%)
3-Year Target
$75.16
(+5%)
3-Yr Target (if PE normalizes)
(PE: 19→18)
PE COMPRESSION
$71.33
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.1, Growth: 10.6%)
$111.96
(+57%)
Base:
(SPY PE: 19.1, Growth: 10.6%)
$96.74
(+35%)
Bear:
(PE: 16.2, Growth: 10.6%)
$82.23
(+15%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (24x PE), but valuation improves significantly next year (19x PE) as earnings recover.
Trailing PE: 24.10 | Current EPS (TTM): $3.02
Bull Case
$99.31
(+39%)
Analyst growth 24.1%, PE expands to 26.5
Base Case
$90.28
(+26%)
Market implied 24.1%, PE stable at 24.1
Bear Case
$49.48
(-31%)
Severe decline -20.0%, PE contracts to 20.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: May 18, 2026 12:35 PM ET
Data refreshes hourly during market hours. Next update: 1:35 PM
Data refreshes hourly during market hours. Next update: 1:35 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CNS showing a specific setup today?
Insider Activity (6 Months)
1
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Francis C Poli
SELL
10000 shares
2026-02-12
Francis C Poli
SELL
9696 shares
2026-02-11
Martin Cohen
BUY
12708 shares
2025-11-20
Top Rated Asset Management Stocks
Top-rated stocks in Asset Management by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BLK
BlackRock Inc |
STRONG BUY
17 analysts |
$1254 | 68 BUY |
|
APO
Apollo Global Management… |
STRONG BUY
19 analysts |
$150 | 59 HOLD |
|
HASI
Hannon Armstrong Sustain… |
STRONG BUY
16 analysts |
$49 | 59 HOLD |
|
BX
Blackstone Group Inc |
HOLD
23 analysts |
$144 | 51 HOLD |
|
ARCC
Ares Capital Corporation |
STRONG BUY
13 analysts |
$21 | 59 HOLD |
